3Di Castelnuovo A,,de Gaetano G,Benedetta Donati M,et al.Plateletglycoprotein IIb/IIIa polymorphismand coronary artery disease:implica-tions for clinical practice. American Journal of Pharmacogenomics . 2005
4Barragan P,Bouvier JL,Roquebert PO,et al.Resistance to thienopyridines:clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheterization and Cardiovascular Interventions . 2003
5Mehta SR,Yusuf S,Peters RJ,et al.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet,The . 2001
6Matetzky S,Shenkman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation . 2004
7Gurbel PA,Bliden KP,Hiatt BL,et al.Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation . 2003
8Lev E I,Patel R T,Maresh K J,et al.Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. Journal of the American College of Cardiology . 2006
9Fontana P,Dupont A,Gandrille S,et al.Adenosine diphosphate-induced platelet aggregation is associated with P2Y12gene sequence variations in healthy subjects. Circulation . 2003
10Lau W C,Gurbel P A,Watkins P B,et al.Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation . 2004
二级参考文献28
1Morais J. Insights from CURE: using clopidogrel on top of standard therapy[J]. Cerebrovasc Dis, 2002,13 (Suppl 1) : 17-21.
2Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a veterans administration cooperative study [J]. N Engl J Med,1987,316:977-984.
3O' Keefe JH Jr,Reeder GS,Miller GA,et al. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic cartheterization compared with that performed at other times [J]. Am J Cardiol, 1989,63 : 27- 29.
4Dunlop LC, Skiner MP, Bendall LJ,et al. Charactorization of GMP-140(P-selectin) as a circulating plasma protein[J]. J Exp Med, 1992,175 (4): 1147- 1155.
5Geiger J, Brich J, Honig - Liedl P, et al. Specific impairment of human platelet P2Y(AC) ADP receptor mediated signaling by the antiplatelet drug clopidogrel[J]. Arterioscler Thromb Vasc Bio1,1999,19(8):2007-2011.
6Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effent with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans[J]. Circulation, 2000,101 (24) : 2823- 2828.
7Müller I, Besta F, Schulz C, et al. Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation, 2003, 108: 2195-2197.
8Gorchakova O, von Beckerath N, Gawaz M, et al. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. Eur Heart J, 2004, 25: 1898-1902.
9von Beckerath N, Gorchakova O, Motz A, et al. Full antiplatelet effect of a loading dose clopidogrel in the presence of statin therapy. Circulation, 2003, 108(suppl): IV-160.
10Serebruany VL, Malinin AI, Callahan KP, et al. Statins do not affect platelet inhibition with clopidogrel during coronary stenting. Atherosclerosis, 2001, 159: 239-241.
